Market Analysis - Hematologists 2017
Name: 7th World Hematologists Congress
Date: May 08-09, 2017
Venue: Barcelona, Spain
Theme: A Step towards Excellence in Hematology Research
Hematology Market Study
The global Hematology diagnostics and drugs market is likely to expand from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a five-year compound annual growth rate (CAGR) of 7.5%. A Blood disorder, the chief segment is anticipated to reach nearly $57.3 billion and $80 billion in 2015 and 2020, respectively, representing five-year CAGR of 6.9%. Hematological oncology is the fastest-growing segment, should raise almost $24 billion in 2015 to $38.2 billion in 2020 at a five-year CAGR of 9.7%. Reagents and diagnostics as a segment should reach $6.1 billion in 2020 at a five-year CAGR of 3.2%.
The Americas controlled the largest share of 41.75% of the worldwide Hematology market at a predicted $1,810.4 million in 2013, anticipated to reach $2,479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. Europe holds the second largest Hematology market share. Germany controlled the largest share almost 20% of the European market at an expected $272.8 million in 2013, and is estimated to grasp $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The Asia and Middle East Hematology market is growing in double digits and will remain to grow in the upcoming years. China controlled the largest share of almost 53% of the Asian Hematology market at an expected $216.0 million in 2013, estimated and is to grasp $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018.
Importance & Scope
The Importance of Hematologists 2017 is to update, clinically significant audience concerning the proof supporting current Advances in diagnosis and treatment in the field of Hematology and Blood Disorders. Researchers and scientists across the globe will interchange views and concepts. Students/Scholars from diverse universities gather together and enhance their knowledge. Diagnostic and Pharmaceutical firms will exhibit their novel products and services, which allow them to develop their business internationally.
Hematologists 2017 is an international platform for presenting research, interchanging concepts concerning it and therefore, contributes towards spreading information in research techniques, in diagnosis and prevention of blood and Hematologic disorders etc. for the advantage of each young researchers, Pharmaceutical firms, scientists and academia. Hematologists 2017 is wherever the longer term of exhibit new diagnostics methods and Instruments used for treatment and diagnosis and novel medicine. This event brings along senior brand marketers and agency executives to explore promoting and advertising opportunities on Pharmaceutical corporations.
- Young Researchers
- Medical Students
- Physicians/Consultants/ General Practitioners
- Presidents & Vice Presidents/ Directors / Administrators
- Business Entrepreneurs
- Haematology Pharma Companies
- Medical Devices Companies
- Hematology Associations/ Societies